More than a million children in Ghana, Kenya and Malawi have now received at least one dose of the first anti-malaria vaccine, the World Health Organization said Thursday.
GENEVA, Switzerland —
“This vaccine is not just a scientific breakthrough, it’s life-changing for families across Africa,” WHO Director-General Tedros Adhanom Ghebreyesus said in the statement. RTS,S, manufactured by British pharmaceutical giant GSK, acts against plasmodium falciparum, the most deadly mosquito-borne parasite around the world and the most prevalent in Africa.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut: